526 related articles for article (PubMed ID: 31167919)
1.
Meng T; Jia Q; Wong SM; Chua KB
J Virol; 2019 Sep; 93(17):. PubMed ID: 31167919
[TBL] [Abstract][Full Text] [Related]
2. A Novel Attenuated Enterovirus A71 Mutant with VP1-V238A,K244R Exhibits Reduced Efficiency of Cell Entry/Exit and Augmented Binding Affinity to Sulfated Glycans.
Meng T; Wong SM; Chua KB
J Virol; 2021 Oct; 95(22):e0105521. PubMed ID: 34468173
[TBL] [Abstract][Full Text] [Related]
3. Glycyrrhizic acid as the antiviral component of Glycyrrhiza uralensis Fisch. against coxsackievirus A16 and enterovirus 71 of hand foot and mouth disease.
Wang J; Chen X; Wang W; Zhang Y; Yang Z; Jin Y; Ge HM; Li E; Yang G
J Ethnopharmacol; 2013 May; 147(1):114-21. PubMed ID: 23454684
[TBL] [Abstract][Full Text] [Related]
4. Lycorine Derivative LY-55 Inhibits EV71 and CVA16 Replication Through Downregulating Autophagy.
Wang H; Guo T; Yang Y; Yu L; Pan X; Li Y
Front Cell Infect Microbiol; 2019; 9():277. PubMed ID: 31448243
[TBL] [Abstract][Full Text] [Related]
5.
Caine EA; Osorio JE
J Virol; 2017 Mar; 91(5):. PubMed ID: 27974562
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of a Trivalent Hand, Foot, and Mouth Disease Vaccine against Enterovirus 71 and Coxsackieviruses A16 and A6 in Mice.
Caine EA; Fuchs J; Das SC; Partidos CD; Osorio JE
Viruses; 2015 Nov; 7(11):5919-32. PubMed ID: 26593938
[TBL] [Abstract][Full Text] [Related]
7. Single Neutralizing Monoclonal Antibodies Targeting the VP1 GH Loop of Enterovirus 71 Inhibit both Virus Attachment and Internalization during Viral Entry.
Ku Z; Ye X; Shi J; Wang X; Liu Q; Huang Z
J Virol; 2015 Dec; 89(23):12084-95. PubMed ID: 26401034
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of enterovirus 71 replication and viral 3C protease by quercetin.
Yao C; Xi C; Hu K; Gao W; Cai X; Qin J; Lv S; Du C; Wei Y
Virol J; 2018 Jul; 15(1):116. PubMed ID: 30064445
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rb1 is an immune-stimulatory agent with antiviral activity against enterovirus 71.
Kang N; Gao H; He L; Liu Y; Fan H; Xu Q; Yang S
J Ethnopharmacol; 2021 Feb; 266():113401. PubMed ID: 32980486
[TBL] [Abstract][Full Text] [Related]
10. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
Lyu K; He YL; Li HY; Chen R
J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050
[TBL] [Abstract][Full Text] [Related]
11. A Single Mutation in the VP1 Gene of Enterovirus 71 Enhances Viral Binding to Heparan Sulfate and Impairs Viral Pathogenicity in Mice.
Ke X; Zhang Y; Liu Y; Miao Y; Zheng C; Luo D; Sun J; Hu Q; Xu Y; Wang H; Zheng Z
Viruses; 2020 Aug; 12(8):. PubMed ID: 32823486
[TBL] [Abstract][Full Text] [Related]
12. A Neonatal Murine Model of Coxsackievirus A6 Infection for Evaluation of Antiviral and Vaccine Efficacy.
Zhang Z; Dong Z; Wei Q; Carr MJ; Li J; Ding S; Tong Y; Li D; Shi W
J Virol; 2017 May; 91(9):. PubMed ID: 28250116
[TBL] [Abstract][Full Text] [Related]
13. Antiviral screen identifies EV71 inhibitors and reveals camptothecin-target, DNA topoisomerase 1 as a novel EV71 host factor.
Wu KX; Chu JJ
Antiviral Res; 2017 Jul; 143():122-133. PubMed ID: 28427827
[TBL] [Abstract][Full Text] [Related]
14. Antiviral effects of two Ganoderma lucidum triterpenoids against enterovirus 71 infection.
Zhang W; Tao J; Yang X; Yang Z; Zhang L; Liu H; Wu K; Wu J
Biochem Biophys Res Commun; 2014 Jul; 449(3):307-12. PubMed ID: 24845570
[TBL] [Abstract][Full Text] [Related]
15. Human SCARB2-dependent infection by coxsackievirus A7, A14, and A16 and enterovirus 71.
Yamayoshi S; Iizuka S; Yamashita T; Minagawa H; Mizuta K; Okamoto M; Nishimura H; Sanjoh K; Katsushima N; Itagaki T; Nagai Y; Fujii K; Koike S
J Virol; 2012 May; 86(10):5686-96. PubMed ID: 22438546
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Coxsackievirus A6- and Enterovirus 71-Associated Hand Foot and Mouth Disease in Beijing, China, from 2013 to 2015.
Li J; Sun Y; Du Y; Yan Y; Huo D; Liu Y; Peng X; Yang Y; Liu F; Lin C; Liang Z; Jia L; Chen L; Wang Q; He Y
Front Microbiol; 2016; 7():391. PubMed ID: 27065963
[TBL] [Abstract][Full Text] [Related]
17. Replication and cytokine profiles of different subgenotypes of enterovirus 71 isolated from Thai patients in peripheral blood mononuclear cells.
Wongsa A; Noulsri E; Phawong C; Puthavathana P; Tassaneetrithep B
Microb Pathog; 2019 Jul; 132():215-221. PubMed ID: 31075431
[TBL] [Abstract][Full Text] [Related]
18. Cathelicidin antimicrobial peptides suppress EV71 infection via regulating antiviral response and inhibiting viral binding.
Yu J; Dai Y; Fu Y; Wang K; Yang Y; Li M; Xu W; Wei L
Antiviral Res; 2021 Mar; 187():105021. PubMed ID: 33508330
[TBL] [Abstract][Full Text] [Related]
19. A Single Mutation in the VP1 of Enterovirus 71 Is Responsible for Increased Virulence and Neurotropism in Adult Interferon-Deficient Mice.
Caine EA; Moncla LH; Ronderos MD; Friedrich TC; Osorio JE
J Virol; 2016 Oct; 90(19):8592-604. PubMed ID: 27440896
[TBL] [Abstract][Full Text] [Related]
20. Structure, Immunogenicity, and Protective Mechanism of an Engineered Enterovirus 71-Like Particle Vaccine Mimicking 80S Empty Capsid.
Wang X; Ku Z; Zhang X; Ye X; Chen J; Liu Q; Zhang W; Zhang C; Fu Z; Jin X; Cong Y; Huang Z
J Virol; 2018 Jan; 92(1):. PubMed ID: 29070691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
